Therefore, the functional role of PMCA1 in kidney injury and hypertension provoked by Ang II treatment must be further investigated, using in vitro renal cell lines (e.g., intracellular calcium concentration measurements/siRNAs) or animal models genetically modifying kidney‐specific PMCA1 expression. The gene discussed is ATP2B1; the disease is Hypertension.